alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › key

key

3 studies tagged key, dated 1987-02-01 to 2025-06-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer's disease 2025-06-09
  2. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease 1999-01-01
  3. Ammonia: key factor in the pathogenesis of hepatic encephalopathy 1987-02-01

Studies

3 studies carry this tag.

Date range

1987 to 2025

Top journals

  • Journal of neural transmission (Vienna, Austria : 1996) 1
  • Med (New York, N.Y.) 1
  • Neurochemical pathology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Med (New York, N.Y.) 2025-06-09 Biomarkers

    In AD-converters (N = 158, 377 samples), higher plasma GFAP levels are observed 10 years prior to the onset of cognitive impairment due to AD compared with individuals who remain cognitively unimpaired (N = 160, 379 samples).

  2. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neural transmission (Vienna, Austria : 1996) 1999-01-01 Biomarkers

    The activities of hexokinase, aldolase, pyruvate kinase, lactate dehydrogenase and glucose 6-phosphate dehydrogenase were determined in brains of patients with Alzheimer's disease (AD) and in age matched controls.

  3. Ammonia: key factor in the pathogenesis of hepatic encephalopathy

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurochemical pathology 1987-02-01 Tau biomarkers

    There is substantial clinical and experimental evidence to suggest that ammonia toxicity is a major factor in the pathogenesis of hepatic encephalopathy associated with subacute and chronic liver disease.

All topic tags with their study counts